Suchergebnisse - "Parfrey, Patrick S"

PubPharm (8)

1

Evocalcet in the management of secondary hyperparathyroidism in dialysis patients

enthalten in: Kidney international | 2018

von Parfrey, P.

CommentOn: Kidney Int. 2018 Oct;94(4):818-825. - PMID 30049473

2

On peginesatide and anemia treatment in CKD

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2013

von Parfrey, P. | Warden, G. | Barrett, B.

CommentOn: N Engl J Med. 2013 Jan 24;368(4):307-19. - PMID 23343061

3

Cinacalcet for cardiovascular disease in patients undergoing dialysis

enthalten in: The New England journal of medicine | 2013

von Chertow, G. | Parfrey, P.

CommentOn: N Engl J Med. 2012 Dec 27;367(26):2482-94. - PMID 23121374

4

BNP in hemodialysis patients

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2010

von Parfrey, P.

CommentOn: Clin J Am Soc Nephrol. 2010 Jun;5(6):1036-40. - PMID 20507952

5

Quality of life in CKD patients treated with erythropoiesis-stimulating agents

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2010

von Parfrey, P. | Wish, T.

CommentOn: Am J Kidney Dis. 2010 Mar;55(3):519-34. - PMID 20031287

6

Angiotensin-receptor blockers in the prevention or treatment of microalbuminuria

enthalten in: Annals of internal medicine | 2009

von Parfrey, P.

CommentOn: Ann Intern Med. 2009 Jul 7;151(1):11-20, W3-4. - PMID 19451554

7

Inhibitors of the renin angiotensin system : proven benefits, unproven safety

enthalten in: Annals of internal medicine | 2008

von Parfrey, P.

CommentOn: Ann Intern Med. 2008 Jan 1;148(1):30-48. - PMID 17984482

8

Target hemoglobin level for EPO therapy in CKD

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2006

von Parfrey, P.

CommentOn: Am J Kidney Dis. 2006 Jan;47(1):24-36. - PMID 16377382

1
[1]